Safe handling of cytotoxics: guideline recommendations.

BACKGROUND This evidence-based practice guideline was developed to update and address new issues in the handling of cytotoxics, including the use of oral cytotoxics; the selection and use of personal protective equipment; and treatment in diverse settings, including the home setting. METHODS The guideline was developed primarily from an adaptation and endorsement of an existing guideline and from three systematic reviews. Before publication, the guideline underwent a series of peer and external reviews to gather feedback. All comments were addressed, and the guideline was amended when required. The guideline applies to health care workers who could come into contact with cytotoxic drugs at any point in the medication circuit. The intended users are hospital administrators, educators, and managers; occupational health and safety services; and pharmacy and health care workers. RESULTS The recommendations represent a reasonable and practical set of procedures that the intended users of this guideline should implement to minimize opportunities for accidental exposure. They are not limited to just the point of care; they cover the entire chain of cytotoxics handling from the time such agents enter the institution until they leave in the patient or as waste. CONCLUSIONS Reducing the likelihood of accidental exposure to cytotoxic agents within the medication circuit is the main objective of this evidenced-based guideline. The recommendations differ slightly from earlier guidelines because of the availability of new evidence.

[1]  M. Slawson,et al.  Workplace Contamination with Antineoplastic Agents in a New Cancer Hospital Using a Closed-System Drug Transfer Device , 2007 .

[2]  M. Carey,et al.  Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A Gafni,et al.  The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Pérol,et al.  The PhaSeal® system: Impact of its use on workplace contamination and duration of chemotherapy preparation , 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[5]  S. Kirsa,et al.  Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device , 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[6]  J. Jaakkola,et al.  Occupational exposures and adverse pregnancy outcomes among nurses: a systematic review and meta-analysis. , 2010, Journal of women's health.

[7]  Carissa M Rocheleau,et al.  Occupational exposures among nurses and risk of spontaneous abortion. , 2012, American journal of obstetrics and gynecology.

[8]  I. Roos,et al.  Human resource issues in cytotoxic drug dispensing , 1997 .

[9]  P. Sessink,et al.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device , 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[10]  Elisabeth Burdick,et al.  Impact of robotic antineoplastic preparation on safety, workflow, and costs. , 2012, Journal of oncology practice.

[11]  S. Kumagai,et al.  Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan , 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.